Skip to main content

Advertisement

Table 1 Patients’ demographics of all included patients after curative intended pancreas surgery due to pancreatic ductal adenocarcinoma (n = 251)

From: Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data

 Median (range)
Age (years)67 (30–88)
BMI (kg/m2)24.6 (15–39)
 n (%)
Gender (female/male)131/120 (52%/48%)
Smokers53 (21%)
Alcohol abuse28 (11%)
ASA Score [12]
 I13 (5%)
 II152 (61%)
 III81 (33%)
 IV3 (1%)
Common comorbidities
 Hypertension133 (54%)
 Post pancreatitis125 (50%)
 Hepatic disease100 (40%)
 Coronary heart disease43 (17%)
 Pulmonary disease33 (13%)
 Renal insufficiency30 (12%)
 Diabetes28 (11%)
Localization of tumor
 Head209 (83%)
 Body16 (7%)
 Tail26 (10%)
Type of surgery
 Pancreatoduodenectomy190 (76%)
 Distal pancreatectomy29 (13%)
 Total pancreatectomy32 (11%)
Complications
 Intraoperative complication18 (7%)
 Postoperative complication143 (57%)
 Operative revision38 (15%)
 median (range)
Hospital stay (days)
 Overall18 (7–63)
 Intensive care unit5 (1–32)
Drain remove (days)7 (0–62)